The FYa and FYb antigens were reported in 1950 and 1951 respectively. Anti-FYb has been implemented in immediate and delayed Haemolytic Transfusion reactions and Haemolytic Disease in the new born. Indirect agglutination of red cells that carry the FYb - antigen occurs in the antiglobulin phase.  In the absence of the FYb- antigen, no indirect agglutination is generally observed.

The Fortress Diagnostics Anti-FYB reagent consists of human serum diluted in sodium chloride solution containing macromolecular potentiators and bovine albumin. The reagent requires no further dilution or addition for recommended techniques.

Product Name Number Kit Size
Anti-Fyb BGFYB002 1 x 2ml

Request a Quote

Please get in touch to see how we can help

Contact Us Quote

Our website use cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and how to manage them see our Privacy & Cookies Policy